"Iowa's really becoming a hotbed for basketball, and that's really exciting to see," said a Cyclone fan who was excited to ...

Alnylam Pharmaceuticals' shares rose about 7% before the bell on Friday following U.S. approval for its drug for a rare and deadly heart disease, securing an entry into a market dominated by Pfizer's ...

China is now a better partner for the European Union in facing global challenges than the United States with Donald Trump in ...

A subset of patients treated with delgocitinib cream 20 mg/g for moderate to severe chronic eczema achieved a “super-response,” by week 16, according to a presenter at the American Academy of ...

Americans are being played. The traditional left-right framework has become obsolete, not because ideological differences ...

How GLP-1 drugs, regulatory concerns, and more factors are shaping the sector. Plus, 3 undervalued healthcare stocks.

This deal promises a long-awaited consolidation among the big six groups, which will now become a big five, and, arguably, a big three as Omnicom, Publicis and WPP open up a gap on Dentsu and Havas, ...

State hasn’t shaken off the Cayman Islands smear and the €14 billion Apple tax money has only reinforced the perception that ...

Pfizer’s Emblaveo has been approved in the EU with a first-in-class indication in multidrug-resistant (MDR) infections. The drug – a combination of beta-lactam antibiotic aztreonam with beta ...

It's officially spring, and as we move into this new season, there are plenty of opportunities to have fun with the whole ...

Like millions of others, I watched Pfizer's Super Bowl ad showing a young boy's triumph over cancer and promising more treatments in the future. Unlike most (thankfully), I also watched the ad as ...